SEQ is the only DLBCL MRD assay available for clinical use and covered by Medicare SEATTLE, (GLOBE NEWSWIRE) -- Adaptive ...
Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.
Jessica Tarlov didn't hold back on "The Five" as she gave Democrats props for their counter-messaging to the president.
7 小时
Zacks Investment Research on MSNQuidelOrtho Unveils Results Manager System to Streamline TestingQuidelOrtho QDEL recently launched the Results Manager System, a cutting-edge solution designed to streamline diagnostic data management and improve workflow efficiency in laboratories. This ...
We have written at length about the U.S. Food and Drug Administration’s (FDA’s) actions to promulgate regulations specifying the agency’s authority ...
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...
Lincoln Minerals has begun a detailed assay program targeting base metal intervals in unassayed drill cores at the Minbrie Project.
Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) (“Wallbridge” or the “Company”) is pleased to announce that it has received final assay results ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
Lincoln Minerals is re-assaying historic core aiming to uncover new base metal potential in South Australia after it was only ...
2 天
News-Medical.Net on MSNGilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering ...Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Schematic representation of the assay. (Photo credit: Justo et al., 2024) Using the knowledge gained in the sandwich ELAA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果